CN1222351A - 复方滴鼻液 - Google Patents

复方滴鼻液 Download PDF

Info

Publication number
CN1222351A
CN1222351A CN 98125718 CN98125718A CN1222351A CN 1222351 A CN1222351 A CN 1222351A CN 98125718 CN98125718 CN 98125718 CN 98125718 A CN98125718 A CN 98125718A CN 1222351 A CN1222351 A CN 1222351A
Authority
CN
China
Prior art keywords
nose drop
nasal
naphazoline
dexamethasone
compound nose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98125718
Other languages
English (en)
Inventor
陈振钰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 98125718 priority Critical patent/CN1222351A/zh
Publication of CN1222351A publication Critical patent/CN1222351A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明提供了一种复方滴鼻液。它是按配比为浓度是0.03～0.06%的滴鼻净3～5ml、庆大霉素4～8万单位、病毒唑0.1～0.2g、氟美松1.6～2.2mg混合配制而成。适于治疗鼻炎、鼻窦炎、鼻粘膜充血、水肿等鼻子疾病,也能用于婴幼儿,其疗效明显巩固、时效长、无毒副作用,系一种治疗鼻子疾病的新药。

Description

复方滴鼻液
本发明涉及一种医药制剂，尤其是一种治疗鼻子疾病的复方药剂。
鼻子是人的嗅觉器官和呼吸器官。因此诸如鼻炎、鼻窦炎等鼻子疾病直接影响着人体健康。在现有药品中，通常用于治疗鼻子疾病的主要是滴鼻净、鼻眼净、麻可液等。这些药品虽有一定的疗效，但时效短、用药频繁，尤其滴鼻净-拟肾上腺素药物浓度高达0.1％，副作用大，易造成鼻甲肥厚或医源性不可逆的鼻粘膜萎缩性鼻炎，特别是不适于婴幼儿使用，使得药剂的应用受到限制。
本发明之目的是提供一种疗效明显、时效长，无副作用的治疗鼻子疾病的新药剂。
为实现上述目的，本发明采用的技术方案是：将滴鼻净、庆大霉素、病素唑、氟美松这4种药按配比为：浓度是0.03～0.06％的滴鼻净3～5ml、庆大霉素4～8万单位、病毒唑0.1～0.2g、氟美松1.6～2.2mg混合配制成为复方滴鼻液。
由于本发明采用低浓度的滴鼻净药液，配加庆大霉素对革兰氏阴性菌、阳性菌都有较强的抑制或杀灭作用，对温度、酸碱度稳定性强；配加了病毒唑对呼吸道感染滴鼻有较好的杀灭病毒的疗效；配加了氟美松对充血水肿的鼻粘膜能起到抗炎、抗过敏、减轻局部水肿的作用。由上述四种药物复配成的复方滴鼻液经数例临床应用证明，其药物配伍合理，疗效明显巩固、时效长，有效率98％以上，无毒副作用。它适用于治疗鼻炎、鼻窦炎、鼻粘膜充血、水肿等鼻子疾病，又可预防和治疗初起感冒，尤其是也能用于婴幼儿治疗，系一种治疗鼻子疾病的新药。
下面是本发明的具体实施例。
实施例1：
采用配比为：浓度是0.05％的滴鼻净4ml、庆大霉素4万单位、病毒唑0.18g、氟美松2mg，相互混合配制成复方滴鼻液。
实施例2：
采用配比为：浓度是0.04％的滴鼻净5ml、庆大霉素8万单位、病毒唑0.16g、氟美松1.8mg，相互混合配制成复方滴鼻液。

Claims (1)

1、一种复方滴鼻液，它包括滴鼻净药液，其特征是还包括庆大霉素、病毒唑、氟美松，按配比为：浓度是0.03～0.06％的滴鼻净3～5ml、庆大霉素4～8万单位、病毒唑0.1～0.2g、氟美松1.6～2.2mg混合配制而成。
CN 98125718 1998-12-11 1998-12-11 复方滴鼻液 Pending CN1222351A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98125718 CN1222351A (zh) 1998-12-11 1998-12-11 复方滴鼻液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98125718 CN1222351A (zh) 1998-12-11 1998-12-11 复方滴鼻液

Publications (1)

Publication Number Publication Date
CN1222351A true CN1222351A (zh) 1999-07-14

Family

ID=5229310

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98125718 Pending CN1222351A (zh) 1998-12-11 1998-12-11 复方滴鼻液

Country Status (1)

Country Link
CN (1) CN1222351A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007104070A1 (en) * 2006-03-14 2007-09-20 Wholesome Biopharm Pty Ltd Method and composition for treating allergic diseases
CN101380328B (zh) * 2007-09-03 2010-08-04 李想 一种治疗鼻炎的药物及其制备方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007104070A1 (en) * 2006-03-14 2007-09-20 Wholesome Biopharm Pty Ltd Method and composition for treating allergic diseases
AU2006339963B2 (en) * 2006-03-14 2010-02-25 Wholesome Biopharm Pty Ltd Method and composition for treating allergic diseases
US8258104B2 (en) 2006-03-14 2012-09-04 Wholesome Biopharm Pty Ltd. Method and composition for treating allergic diseases
CN101380328B (zh) * 2007-09-03 2010-08-04 李想 一种治疗鼻炎的药物及其制备方法

Similar Documents

Publication Publication Date Title
US5801199A (en) Pharmaceutical composition for treating acute rhinitis
CN101757117A (zh) 一种中草药调理剂及其制备方法
CN101480382A (zh) 一种治疗急慢性鼻窦炎的药物组合物及其制备方法
CN1222351A (zh) 复方滴鼻液
CN1294930C (zh) 一种治疗上呼吸道炎所致咳嗽的药物
CN102166334B (zh) 一种治疗婴儿湿疹和老年皮肤瘙痒的外用药及其制法
CN103083404A (zh) 鼻腔保护剂
CN101390849A (zh) 一种大蒜新素组合物及在其制备治疗鼻腔微生物感染中的滴剂的方法和应用
CN1263470C (zh) 治疗感冒的外用滴鼻剂及制备方法
CN109646438A (zh) 去甲乌药碱或其盐酸盐在制备治疗鼻炎药物中的应用
CN103585330B (zh) 一种用于皮肤真菌感染的中药组合物及其制备方法
CN103585460B (zh) 一种用于牙龈止血的填塞剂
CN1123146A (zh) 抗感冒药物
CN106166273A (zh) 一种耳鼻喉护理外用药及其制备方法
CN1989950A (zh) 灭菌特效止痒搽剂
CN2652423Y (zh) 可置入鼻孔内的呼吸给药装置
CN1164283C (zh) 一种治疗肺炎的中药散剂
CN100387249C (zh) 一种治疗溃疡的中药制剂
CN105031507A (zh) 一种红花酊抗菌液及其制备方法
CN116059327A (zh) 一种溶菌酶鼻腔喷雾剂及其制备方法
CN2483025Y (zh) 可置入鼻孔内的呼吸给药装置
CN1861088A (zh) 鼻炎鼻窦炎滴鼻液
EP1249242B1 (en) Natural-Phytotherapic composition based on hydroglyceric extracts for aerosol therapy
Welch Local anesthetic toxicosis
CN102697980A (zh) 治疗上呼吸道感染的组合物、制剂及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1044729

Country of ref document: HK